Groups | Pre-disease group | Mixed period group | Disease group | F/χ 2 | P | Controls | |
---|---|---|---|---|---|---|---|
Variables | |||||||
TSH | levels | 2.48 ± 1.537 | 2.61 ± 3.399 | 2.16 ± 1.706 | 7.153 | 0.028 | 2.28 ± 1.28 |
ARa | 9.10% | 14.80% | 6.80% | 4.073 | 0.130 | 8.12% | |
TT3 | levels | 1.64 ± 0.575 | 1.5 ± 0.477 | 1.42 ± 0.421 | 15.537 | 0.000 | 1.63 ± 0.25 |
ARa | 7.80% | 37.00% | 8.10% | 39.044 | 0.000 | 5.63% | |
FT3 | levels | 4.70 ± 1.214 | 4.49 ± 1.108 | 4.2 ± 1.136 | 6.485 | 0.002 | 4.97 ± 0.69 |
ARa | 19.50% | 16.70% | 8.10% | 10.062 | 0.007 | 3.13% | |
TT4 | levels | 105.51 ± 32.832 | 67.59 ± 37.517 | 89.6 ± 23.189 | 36.596 | 0.000 | 96.03 ± 16.26 |
ARa | 6.50% | 27.80% | 5.50% | 30.175 | 0.000 | 0.63% | |
FT4 | levels | 14.70 ± 4.129 | 13.36 ± 9.572 | 12.74 ± 2.969 | 20.132 | 0.000 | 16.90 ± 2.94 |
ARa | 18.20% | 31.50% | 3.90% | 47.377 | 0.000 | 3.75% | |
AR of HPT axis | 39% | 57.40% | 21.60% | 33.074 | 0.000 | 15.63% | |
ACTH | levels | 36.79 ± 33.077 | 42.52 ± 33.421 | 30.42 ± 22.204 | 6.362 | 0.042 | 24.66 ± 11.89 |
ARa | 18.20% | 7.40% | 10.30% | 4.736 | 0.094 | 0.63% | |
COR | levels | 656.74 ± 311.641 | 577.35 ± 234.275 | 407.56 ± 170.571 | 75.555 | 0.000 | 386.77 ± 109.85 |
ARa | 39.00% | 35.20% | 8.40% | 55.256 | 0.000 | 1.88% | |
AR of HPA axis | 45.50% | 35.20% | 18.10% | 28.164 | 0.000 | 2.5% | |
AR of biax | 14.30% | 22.20% | 3.50% | 28.208 | 0.000 | 0.6% |